MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank60
3Y CAGR+76.8%
5Y CAGR+29.5%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+76.8%/yr
Annual compound
5Y CAGR
+29.5%/yr
Recent acceleration
Percentile
P60
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$424.43M-11.2%
2024$477.93M-9.2%
2023$526.54M+585.2%
2022$76.84M+693.6%
2021$9.68M-91.7%
2020$116.63M-